Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on: January 13,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on:January 13,2024

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on: January 30,2024

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on:January 30,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on: April 09,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on:April 09,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on: January 11,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on:January 11,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Updated on: April 29,2025

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Updated on:April 29,2025

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on: January 30,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on:January 30,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on: March 25,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on:March 25,2024

Study links gene mutations to heart rhythm risks seen in cancer patients

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of

Updated on: September 13,2024

Study links gene mutations to heart rhythm risks seen in cancer patients

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of

Updated on:September 13,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on: March 20,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on:March 20,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on: July 17,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on:July 17,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024